Description: BIFIDO Co., Ltd produces probiotics based products. It offers bifidobacterium strain products, such as BGN4 for immune modulating; BORI used to treat rotavirus infection in infants; and AD011 for general intestinal health problems. The company was founded in 1999 and is headquartered in Hongcheon, South Korea.
Home Page: www.bifido.com
23-16 Nonggongdanji-gil
Hongcheon,
25117
South Korea
Phone:
82 3 3435 4962
Exchange: KQ
Country: KR
Currency: Korean Won (₩)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 3.5839 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 78 |